[sheet: Closing Checklist]
Item No. | Category | Document Description | Responsible Party | Counterparty / Recipient | Due Date | Delivery Status | Date Delivered | Notes
1 | I. Core Transaction Documents | Asset Purchase Agreement — Execution Version (dated April 2, 2024), between Ardent Healthcare Acquisition Corp. and Cardinal Peak Industries, Inc. | Calderwood & Harkness LLP / Barrow, Kensington & Pratt LLP | All Parties | June 30, 2024 | Delivered | April 2, 2024 (signed); June 30, 2024 (closing) | Base Purchase Price: $620,000,000; DE governing law; executed April 2, 2024; closing effected June 30, 2024
2 | I. Core Transaction Documents | Disclosure Schedules to Asset Purchase Agreement (Buyer's and Seller's schedules) | Calderwood & Harkness LLP / Barrow, Kensington & Pratt LLP | Buyer / Seller | April 2, 2024 | Delivered | April 2, 2024 | Delivered concurrently with APA execution; covers excluded assets, excluded liabilities, material contracts, real property leases (37 locations), IP (PeakConnect, U.S. Reg. No. 5,412,887), Dawson litigation (Case No. 3:23-cv-01847), employee matters, healthcare permits, environmental, insurance
3 | I. Core Transaction Documents | Bill of Sale — CPI to Ardent Healthcare Acquisition Corp. | Calderwood & Harkness LLP | Buyer | June 30, 2024 | Delivered | June 30, 2024 | Transfers all personal property assets included in acquired assets
4 | I. Core Transaction Documents | Assignment and Assumption Agreement — CPI (assignor) to Ardent Healthcare Acquisition Corp. (assignee) | Calderwood & Harkness LLP | Buyer / Seller | June 30, 2024 | Delivered | June 30, 2024 | Assigns assumed contracts and assumed liabilities (trade payables, assumed contract obligations, accrued PTO); expressly excludes Dawson litigation and pre-closing tax liabilities
5 | I. Core Transaction Documents | Intellectual Property Assignment Agreement — PeakConnect platform and trademarks (U.S. Reg. No. 5,412,887), with 12-month license-back of Cardinal Peak Industries corporate name | Calderwood & Harkness LLP | Buyer / Seller | June 30, 2024 | Delivered | June 30, 2024 | Includes PeakConnect patient-engagement software; 12-month CPI name license-back
6 | I. Core Transaction Documents | Transition Services Agreement — CPI to provide transitional back-office, IT, and administrative services for up to 9 months post-closing | Calderwood & Harkness LLP / Barrow, Kensington & Pratt LLP | Buyer / Seller | June 30, 2024 | Delivered | June 30, 2024 | Service schedules, pricing, and termination provisions; HIPAA BAA required
7 | I. Core Transaction Documents | Earnout Agreement — EBITDA earnout calculation, up to $45,000,000 aggregate; Tranche 1 up to $22,500,000 (Adj. EBITDA ≥ $85M, EP1 ending June 30, 2025); Tranche 2 up to $22,500,000 (Adj. EBITDA ≥ $95M, EP2 ending June 30, 2026); change of control acceleration | Calderwood & Harkness LLP | Buyer / Seller / Seller Shareholders | June 30, 2024 | Delivered | June 30, 2024 | Linear ramp: $4.50 per $1 EBITDA above $80M (Tr. 1) and $90M (Tr. 2) thresholds; change of control acceleration triggers 100% of remaining max earnout; dispute resolution provisions included
8 | II. Seller's Closing Deliverables | Seller's Closing Certificate — bring-down of representations and warranties, compliance with covenants, satisfaction of closing conditions | Barrow, Kensington & Pratt LLP | Buyer | June 30, 2024 | Delivered | June 30, 2024 | Signed by authorized officer of CPI
9 | II. Seller's Closing Deliverables | Secretary's Certificate of Seller — board resolutions authorizing the transaction, incumbency of officers, DE certificate of good standing, certificate of incorporation and bylaws | Barrow, Kensington & Pratt LLP | Buyer | June 30, 2024 | Delivered | June 30, 2024 | Includes DE Secretary of State good standing certificate; CPI DE File No. 5487231
10 | II. Seller's Closing Deliverables | Officer's Certificate re: No Material Adverse Effect — certification that no MAE has occurred from April 2, 2024 through June 30, 2024 | Barrow, Kensington & Pratt LLP | Buyer | June 30, 2024 | Delivered | June 30, 2024 | Covers interim period from APA signing to closing
11 | II. Seller's Closing Deliverables | FIRPTA Certificate — Seller's certification of non-foreign status under IRC § 1445 | Barrow, Kensington & Pratt LLP | Buyer | June 30, 2024 | Delivered | June 30, 2024 | CPI EIN: 82-3947561; address: 8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215
12 | III. Buyer's Closing Deliverables | Buyer's Closing Certificate — bring-down of Buyer's reps and warranties, compliance with covenants, satisfaction of Buyer's closing conditions | Calderwood & Harkness LLP | Seller | June 30, 2024 | Delivered | June 30, 2024 | Signed by authorized officer of Ardent Healthcare Acquisition Corp.
13 | III. Buyer's Closing Deliverables | Secretary's Certificate of Buyer (Ardent Healthcare Acquisition Corp.) — board resolutions, incumbency, certificate of incorporation, DE good standing | Calderwood & Harkness LLP | Seller | June 30, 2024 | Delivered | June 30, 2024 | Acquisition Sub DE File No. 7129384; formed January 22, 2024; registered agent: National Registered Services, Inc., 1209 Orange Street, Wilmington, DE 19801
14 | IV. Employment & Non-Compete | Employment Agreement — Dr. Randall J. Whitfield (CEO), 3-year term commencing June 30, 2024 | Calderwood & Harkness LLP | Dr. Whitfield / Buyer | June 30, 2024 | Delivered | June 30, 2024 | Governed by Tennessee law; 52% shareholder of CPI pre-closing
15 | IV. Employment & Non-Compete | Employment Agreement — Elaine Whitfield-Torres (CCO), 3-year term commencing June 30, 2024 | Calderwood & Harkness LLP | Whitfield-Torres / Buyer | June 30, 2024 | Delivered | June 30, 2024 | Governed by Tennessee law; 18% shareholder of CPI pre-closing
16 | IV. Employment & Non-Compete | Non-Competition and Non-Solicitation Agreement — Dr. Randall J. Whitfield, 3-year restrictive covenant covering TN, GA, NC, SC, AL, VA, KY | Calderwood & Harkness LLP | Dr. Whitfield / Buyer | June 30, 2024 | Delivered | June 30, 2024 | Governed by Tennessee law; covers all 7 states of CPI operations
17 | IV. Employment & Non-Compete | Non-Competition and Non-Solicitation Agreement — Elaine Whitfield-Torres, 3-year restrictive covenant covering TN, GA, NC, SC, AL, VA, KY | Calderwood & Harkness LLP | Whitfield-Torres / Buyer | June 30, 2024 | Delivered | June 30, 2024 | Governed by Tennessee law; covers all 7 states of CPI operations
18 | V. Financing Documents | Senior Secured Credit Agreement — $400,000,000 facility ($310M Term Loan A at SOFR + 325 bps, 5-year; $90M Revolving Credit Facility at SOFR + 300 bps, 5-year, undrawn at closing) — Pinnacle National Bank, N.A. as Administrative Agent and Lead Arranger | Pinnacle National Bank, N.A. / Calderwood & Harkness LLP | Buyer / Lenders | June 30, 2024 | Delivered | June 30, 2024 | NY governing law; syndicate lenders: Horizon Commercial Lending Corp., Tidewater Savings Bank, N.A., Great Plains Capital Partners LLC; commitment letter dated April 2, 2024 (Project Cardinal)
19 | V. Financing Documents | Legal Opinion of Calderwood & Harkness LLP — delivered to Pinnacle National Bank, N.A. as Administrative Agent re: authorization, enforceability, no conflicts, valid existence of Ardent Healthcare Acquisition Corp. | Calderwood & Harkness LLP (Beatrice Holloway) | Pinnacle National Bank, N.A. | June 30, 2024 | Delivered | June 30, 2024 | Covers APA and related agreements; opines on DE valid existence of Acquisition Sub
20 | V. Financing Documents | Funds Flow Memorandum — detailed allocation of all sources and uses at closing | Calderwood & Harkness LLP | All Parties / Pinnacle National Bank | June 30, 2024 | Delivered | June 30, 2024 | Sources: $310M TLA + $220M equity = $530M. Uses: $558M cash to Seller, $62M to escrow (Commonwealth Trust & Escrow Company), $87.4M payoff to Velthorn Merchant Bank, transaction fees, NWC adjustment (est. NWC $29.2M vs. target $28M)
21 | V. Financing Documents | Closing Statement / Settlement Statement — reconciliation of $620M base purchase price with adjustments | Calderwood & Harkness LLP | Buyer / Seller | June 30, 2024 | Delivered | June 30, 2024 | Net cash to Seller shareholders: Dr. Whitfield (52%), Whitfield-Torres (18%), Ridgeline Growth Equity Fund II LP (22%), other management (8%); escrow holdback of $62M; estimated NWC adjustment
22 | VI. Escrow Documents | Escrow Agreement — among Ardent Healthcare Acquisition Corp., Cardinal Peak Industries, Inc., and Commonwealth Trust & Escrow Company | Calderwood & Harkness LLP | Buyer / Seller / Commonwealth Trust & Escrow Company | June 30, 2024 | Delivered | June 30, 2024 | Escrow amount: $62,000,000 (10% × $620M); Tranche 1 release: $31M on June 30, 2025; Tranche 2 release: $31M on December 30, 2025; net of pending indemnification claims; DE governing law; contact: Martin Galbraith, VP, Corporate Trust Services
23 | VI. Escrow Documents | Wire transfer confirmation — $62,000,000 funded to Commonwealth Trust & Escrow Company escrow account | Ardent Capital Partners III LP / Pinnacle National Bank | Commonwealth Trust & Escrow Company | June 30, 2024 | Delivered | June 30, 2024 | Escrow funded from Buyer equity at closing
24 | VII. Payoff & Lien Releases | Payoff Letter — Velthorn Merchant Bank, N.A., confirming outstanding principal of $87,400,000 under Credit Agreement dated March 15, 2018, as amended | Barrow, Kensington & Pratt LLP / Velthorn Merchant Bank | Buyer / Seller | June 26, 2024 | Delivered | June 26, 2024 | Includes per diem interest, wire instructions, and agreement to file UCC termination statements upon receipt
25 | VII. Payoff & Lien Releases | Wire transfer of payoff amount to Velthorn Merchant Bank, N.A. | Calderwood & Harkness LLP (via funds flow) | Velthorn Merchant Bank | June 30, 2024 | Delivered | June 30, 2024 | Payoff of $87,400,000 funded at closing from purchase price proceeds
26 | VII. Payoff & Lien Releases | UCC Termination Statements — filed with DE Secretary of State and TN Secretary of State | Barrow, Kensington & Pratt LLP / Velthorn Merchant Bank | Public filing | June 28, 2024 | Delivered | June 28, 2024 | Filed June 28, 2024; terminates Velthorn security interests in CPI assets
27 | VIII. Regulatory Filings & Consents | State healthcare change-of-ownership notices — Tennessee, Georgia, North Carolina | Hargrove, Sinclair & Demarest LLP (Angela Demarest) / Calderwood & Harkness LLP | State regulatory agencies (TN, GA, NC) | March 4, 2024 | Delivered | March 4, 2024 | Filed for states requiring pre-closing notification; no HSR filing required (below threshold for asset purchase of healthcare clinics, confirmed by counsel)
28 | VIII. Regulatory Filings & Consents | State healthcare change-of-ownership notices — South Carolina, Alabama, Virginia, Kentucky | Hargrove, Sinclair & Demarest LLP | State regulatory agencies (SC, AL, VA, KY) | Various | Delivered | Various dates pre-closing | Filings made as required by each state's regulatory framework; see Healthcare Regulatory Compliance Memorandum dated March 20, 2024
29 | VIII. Regulatory Filings & Consents | HSR Act Filing | N/A | N/A | N/A | N/A | Not required; below threshold for asset purchase of healthcare clinics; confirmed by counsel
30 | VIII. Regulatory Filings & Consents | Medicare/Medicaid change of ownership enrollment updates (CMS-855 forms) | Hargrove, Sinclair & Demarest LLP / Buyer's operations team | CMS / State Medicaid agencies | Post-closing | Pending — Post-Closing | Medicare/Medicaid represent ~31% of CPI net revenue combined; enrollment transfer filings to be submitted promptly post-closing
31 | IX. Landlord Consents | Landlord consents for assignment/change of control — 29 of 37 leased clinic locations require consent | Tiffany Rosenthal (Calderwood & Harkness LLP) / Barrow, Kensington & Pratt LLP | Individual landlords | June 30, 2024 | Delivered (27 of 29); Pending (2) | Various | 27 consents obtained pre-closing; 2 consents (Knoxville, TN clinic and Roanoke, VA clinic) outstanding at closing — Seller providing indemnification; 8 locations did not require consent; see Lease Consent Tracker for full detail; average remaining lease term 4.2 years across 37 locations
32 | X. Insurance | R&W Insurance Policy — Sentinel Specialty Insurance Company, Policy No. SSI-RWI-2024-05178 | Alder Risk Partners LLC (Philip Yuen, SVP) / Calderwood & Harkness LLP | Buyer | April 10, 2024 (bound) | Delivered | April 10, 2024 | Coverage limit: $62,000,000 (10% of purchase price); retention: $6,200,000 (1% of purchase price, 50/50 split Buyer/Seller indemnification basket); underwriting counsel: Caldwell Strand LLP, Chicago, IL; excludes Dawson litigation and known tax matters; coordinates with APA indemnification cap of $124M (20%)
33 | X. Insurance | Evidence of Buyer's liability insurance / D&O coverage for Ardent Healthcare Acquisition Corp. | Ardent Capital Management LLC | Seller / Lenders | June 30, 2024 | Delivered | June 30, 2024 | Required under Credit Agreement and APA
34 | XI. Tax Documents | Draft IRS Form 8594 — Asset Acquisition Statement under IRC § 1060 | Sylvia Hartwell (Calderwood & Harkness LLP, Tax) / Ashford & Creighton LLP | Buyer / Seller | June 30, 2024 (draft); Final post-NWC true-up | Delivered (draft) | June 30, 2024 | Allocates $620M purchase price among 7 asset classes (I–VII); to be finalized after NWC true-up; see Section 338 / Asset Allocation Memorandum dated March 18, 2024
35 | XI. Tax Documents | Tax Structure Memorandum — IRC § 1060 allocation analysis, step-up in basis, state tax considerations across 7 states, earnout treatment as additional purchase price | Sylvia Hartwell (Calderwood & Harkness LLP, Tax) | Internal / Ardent Capital deal team | February 8, 2024 | Delivered | February 8, 2024 | Completed during diligence phase; supplemented by Ashford & Creighton LLP structuring analysis
36 | XII. Post-Closing Obligations | Net Working Capital final determination — NWC Target: $28,000,000; Estimated Closing NWC: $29,200,000; $500,000 de minimis collar | Ashford & Creighton LLP (Gregory Nolan) / Calderwood & Harkness LLP | Buyer / Seller | September 28, 2024 (90 days post-closing) | Pending — Post-Closing | Dollar-for-dollar adjustment above/below NWC Target; no adjustment if difference ≤ $500K; Buyer to deliver proposed final NWC statement within 90 days of closing
37 | XII. Post-Closing Obligations | Earnout monitoring and payment — Tranche 1 (EP1 ends June 30, 2025; max $22.5M); Tranche 2 (EP2 ends June 30, 2026; max $22.5M) | Ardent Healthcare Acquisition Corp. / Ardent Capital Management LLC | Seller / Seller Shareholders | June 30, 2025 (Tr. 1); June 30, 2026 (Tr. 2) | Pending — Post-Closing | Earnout Tranche 1: linear ramp $80M–$85M EBITDA ($4.50/$1); Earnout Tranche 2: linear ramp $90M–$95M EBITDA ($4.50/$1); aggregate cap $45M; change of control acceleration provision
38 | XII. Post-Closing Obligations | Escrow releases — Tranche 1: $31M on June 30, 2025; Tranche 2: $31M on December 30, 2025 (net of pending indemnification claims) | Commonwealth Trust & Escrow Company (Martin Galbraith) | Buyer / Seller | June 30, 2025 / December 30, 2025 | Pending — Post-Closing | Escrow Agent: Commonwealth Trust & Escrow Company, 3801 Kennett Pike, Suite 250, Greenville, DE 19807
39 | XII. Post-Closing Obligations | Indemnification survival tracking — General reps: 18 months (expires December 30, 2025); Fundamental reps: 36 months (expires June 30, 2027); Tax reps: 60 days after statute of limitations | Calderwood & Harkness LLP (Beatrice Holloway / Derek Okonkwo) | Buyer | Ongoing | Pending — Post-Closing | Indemnification cap: $124,000,000 (20% of $620M); basket: $3,100,000 (0.5%, first-dollar tipping); de minimis: $100,000 per claim; exclusive remedy (except fraud, willful breach, equitable relief)
40 | XII. Post-Closing Obligations | TSA wind-down — Transition Services Agreement expires 9 months post-closing (March 30, 2025) | Ardent Healthcare Acquisition Corp. operations team | CPI (Seller) | March 30, 2025 | Pending — Post-Closing | CPI providing back-office, IT, and admin services; HIPAA BAA in place
41 | XII. Post-Closing Obligations | Form 8594 finalization and filing with IRS | Sylvia Hartwell (Calderwood & Harkness LLP) / Ashford & Creighton LLP | IRS | With applicable tax returns | Pending — Post-Closing | To be finalized after NWC true-up; Buyer EIN: 93-2184720; Seller EIN: 82-3947561
42 | XII. Post-Closing Obligations | Document retention — transaction documents to be maintained per Calderwood & Harkness LLP retention policy and client instructions | Calderwood & Harkness LLP | Buyer | Ongoing | Pending — Post-Closing | See Post-Closing Letter to Client dated July 3, 2024
SUMMARY | Total Items: 42 | Delivered: 34 | Pending (Post-Closing): 7 | N/A: 1
[sheet: Summary]
Field | Value
Matter | Acquisition of Cardinal Peak Industries, Inc. by Ardent Healthcare Acquisition Corp.
C&H Matter No. | 2024-M&A-0142
Client | Ardent Capital Partners III LP (590 Madison Avenue, 34th Floor, New York, NY 10022)
Client Contact | Marcus Ainsworth, Managing Partner; Priya Mehta-Sullivan, Partner; Connor Briggs, Vice President
Seller | Cardinal Peak Industries, Inc. (8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215)
Seller's Counsel | Barrow, Kensington & Pratt LLP (Catherine Barrow / Samuel Otieno)
Buyer's Counsel (Responsible Partner) | Beatrice Holloway, Calderwood & Harkness LLP
Billing Partner | James Prentice, Calderwood & Harkness LLP
Lead Associate | Derek Okonkwo, Calderwood & Harkness LLP
Working Associate | Tiffany Rosenthal, Calderwood & Harkness LLP
Tax Partner | Sylvia Hartwell, Calderwood & Harkness LLP
Healthcare Regulatory Counsel | Angela Demarest, Hargrove, Sinclair & Demarest LLP
Base Purchase Price | $620,000,000
Maximum Earnout | $45,000,000
Transaction Structure | Asset Purchase
APA Signing Date | April 2, 2024
Target Closing Date | June 20, 2024
Actual Closing Date | June 30, 2024
Governing Law (APA) | Delaware
Governing Law (Credit Agreement) | New York
Governing Law (Employment/Non-Competes) | Tennessee
Total Checklist Items | 42
Items Delivered | 34
Items Pending (Post-Closing) | 7
Items N/A | 1 (HSR Filing)
Prepared By | Derek Okonkwo / Tiffany Rosenthal, Calderwood & Harkness LLP
Last Updated | July 1, 2024
[sheet: Key Parties & Contacts]
Role | Entity | Contact Person | Title | Address
Buyer | Ardent Capital Partners III LP | Marcus Ainsworth / Priya Mehta-Sullivan / Connor Briggs | Managing Partner / Partner / Vice President | 590 Madison Avenue, 34th Floor, New York, NY 10022
Acquisition Sub (Purchaser) | Ardent Healthcare Acquisition Corp. | Connor Briggs (day-to-day deal lead) | Vice President | c/o National Registered Services, Inc., 1209 Orange Street, Wilmington, DE 19801
Seller | Cardinal Peak Industries, Inc. | Dr. Randall J. Whitfield / Elaine Whitfield-Torres | Chairman & CEO / Co-Founder & CCO | 8400 Crescent Ridge Parkway, Suite 200, Nashville, TN 37215
Minority Shareholder (Seller side) | Ridgeline Growth Equity Fund II LP (GP: Ridgeline Growth Equity Advisors LLC) | 3344 Peachtree Road NE, Suite 1500, Atlanta, GA 30326
Buyer's Counsel | Calderwood & Harkness LLP | Beatrice Holloway (Responsible Partner) / Derek Okonkwo (Lead Associate) / Tiffany Rosenthal (Associate) | Partner / Associate / Associate | One World Financial Center, 200 Liberty Street, 40th Floor, New York, NY 10281
Seller's Counsel | Barrow, Kensington & Pratt LLP | Catherine "Kit" Barrow / Samuel Otieno | Co-Managing Partner / Lead Associate | 1201 Demonbreun Street, Suite 1800, Nashville, TN 37203
Administrative Agent / Lead Arranger | Pinnacle National Bank, N.A. | Laura Fitzgibbons | Managing Director, Healthcare Lending | 300 Vesey Street, New York, NY 10281
Syndicate Lender | Horizon Commercial Lending Corp. | New York, NY
Syndicate Lender | Tidewater Savings Bank, N.A. | Virginia
Syndicate Lender | Great Plains Capital Partners LLC | Kansas
Payoff Bank (Seller's Existing Lender) | Velthorn Merchant Bank, N.A. | Massachusetts
Escrow Agent | Commonwealth Trust & Escrow Company | Martin Galbraith | Vice President, Corporate Trust Services | 3801 Kennett Pike, Suite 250, Greenville, DE 19807
Buyer's Financial Advisor | Graystone Partners LLC | Nathaniel "Nate" Prescott | Managing Director | 787 Seventh Avenue, 22nd Floor, New York, NY 10019
Seller's Financial Advisor | Meridian Oak Advisory Group | Diana Vasquez-Reid | Senior Managing Director | 4000 West End Avenue, Suite 600, Nashville, TN 37205
Buyer's Accounting Advisor | Ashford & Creighton LLP | Gregory Nolan, CPA | Partner, Transaction Advisory Services | One Liberty Plaza, 45th Floor, New York, NY 10006
Seller's Auditor | Linden Hayes & Co., P.C. | Roberta Chen, CPA | Audit Partner | 500 Church Street, Suite 1400, Nashville, TN 37219
R&W Insurance Carrier | Sentinel Specialty Insurance Company | Policy No. SSI-RWI-2024-05178 | Illinois
R&W Insurance Broker | Alder Risk Partners LLC | Philip Yuen | Senior Vice President | 452 Fifth Avenue, 12th Floor, New York, NY 10018
R&W Underwriting Counsel | Caldwell Strand LLP | 155 North Wacker Drive, Suite 3200, Chicago, IL 60606
Healthcare Regulatory Counsel | Hargrove, Sinclair & Demarest LLP | Angela Demarest | Partner, Healthcare Regulatory | 1717 K Street NW, Suite 900, Washington, DC 20006
Title Company | Cornerstone Land Title Company | 222 Second Avenue South, Nashville, TN 37201
Environmental Consultant | Whitmore Environmental Sciences Inc. | 2900 Woodland Park Drive, Atlanta, GA 30339
Registered Agent (Acquisition Sub) | National Registered Services, Inc. | 1209 Orange Street, Wilmington, DE 19801
[sheet: Key Dates Timeline]
Date | Event | Status | Notes
January 15, 2024 | Calderwood & Harkness engagement letter signed; matter opened (Matter No. 2024-M&A-0142) | Completed | Beatrice Holloway (Responsible Partner), James Prentice (Billing Partner)
January 22, 2024 | Ardent Healthcare Acquisition Corp. formed in Delaware | Completed | DE File No. 7129384; EIN 93-2184720
January 29, 2024 | Letter of Intent executed | Completed
February 5, 2024 | Due diligence commenced | Completed
February 8, 2024 | Tax Structure Memorandum circulated (Sylvia Hartwell) | Completed | IRC § 1060 analysis, asset purchase structure
February 12, 2024 | First draft APA circulated by Calderwood & Harkness to Barrow, Kensington & Pratt LLP | Completed
March 4, 2024 | State healthcare change-of-ownership notices filed (TN, GA, NC) | Completed | Filed by Hargrove, Sinclair & Demarest LLP
March 12, 2024 | Litigation and Regulatory Review Memorandum (Derek Okonkwo) | Completed | Dawson v. CPI, Case No. 3:23-cv-01847 (M.D. Tenn.); est. exposure $2.8M–$5.1M
March 18, 2024 | Section 338 / Asset Allocation Memorandum (Sylvia Hartwell) | Completed | Proposed allocation of $620M across asset classes I–VII
March 20, 2024 | Healthcare Regulatory Compliance Memorandum (joint C&H / HSD) | Completed | Anti-kickback / Stark Law analysis; Medicare/Medicaid enrollment
March 25, 2024 | Due Diligence Summary Memorandum circulated | Completed | Comprehensive findings across all legal workstreams
April 2, 2024 | APA signed; Financing commitment letter executed (Project Cardinal) | Completed | Base purchase price $620M; earnout up to $45M; 20% indemnification cap ($124M); 18-month survival; 10% escrow ($62M)
April 8, 2024 | R&W Insurance Coverage Memorandum circulated | Completed | Analysis of Sentinel policy SSI-RWI-2024-05178
April 10, 2024 | R&W insurance policy bound | Completed | Sentinel Specialty Insurance Company; $62M coverage; $6.2M retention
June 14, 2024 | Pre-Closing Deficiency Letter sent to Seller's Counsel | Completed | Outstanding items: certain landlord consents, Velthorn payoff letter, updated good standing, officer's MAE certificate
June 20, 2024 | Target closing date per APA | Passed | Closing delayed to June 30, 2024
June 26, 2024 | Velthorn Merchant Bank payoff letter dated | Completed | Outstanding principal: $87,400,000
June 28, 2024 | UCC termination statements filed (DE and TN) | Completed | Terminates Velthorn security interests
June 30, 2024 | ACTUAL CLOSING DATE | Completed | All closing deliverables exchanged; funds wired
September 28, 2024 | NWC final determination deadline (90 days post-closing) | Upcoming | NWC Target: $28M; Est. Closing NWC: $29.2M; $500K de minimis collar
March 30, 2025 | TSA expiration (9 months post-closing) | Upcoming
June 30, 2025 | Escrow Tranche 1 release ($31M); Earnout Period 1 ends | Upcoming | Earnout Tranche 1: up to $22.5M if Adj. EBITDA ≥ $85M
December 30, 2025 | Escrow Tranche 2 release ($31M); General R&W survival expiration | Upcoming | 18 months post-closing
June 30, 2026 | Earnout Period 2 ends | Upcoming | Earnout Tranche 2: up to $22.5M if Adj. EBITDA ≥ $95M
June 30, 2027 | Fundamental Representations survival expiration | Upcoming | 36 months post-closing